- Home
- CHRW vs NBIX Comparison
CHRW vs NBIX Comparison
Compare CHRW & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRW
- NBIX
- Stock Information
- Founded
- CHRW 1905
- NBIX 1992
- Country
- CHRW United States
- NBIX United States
- Employees
- CHRW N/A
- NBIX N/A
- Industry
- CHRW Oil Refining/Marketing
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CHRW Consumer Discretionary
- NBIX Health Care
- Exchange
- CHRW Nasdaq
- NBIX Nasdaq
- Market Cap
- CHRW 10.7B
- NBIX 12.4B
- IPO Year
- CHRW 1997
- NBIX 1996
- Fundamental
- Price
- CHRW $97.06
- NBIX $131.24
- Analyst Decision
- CHRW Buy
- NBIX Strong Buy
- Analyst Count
- CHRW 20
- NBIX 21
- Target Price
- CHRW $114.26
- NBIX $165.14
- AVG Volume (30 Days)
- CHRW 1.0M
- NBIX 832.3K
- Earning Date
- CHRW 07-30-2025
- NBIX 07-30-2025
- Dividend Yield
- CHRW 2.55%
- NBIX N/A
- EPS Growth
- CHRW 64.94
- NBIX N/A
- EPS
- CHRW 4.19
- NBIX 2.96
- Revenue
- CHRW $17,359,385,000.00
- NBIX $2,412,600,000.00
- Revenue This Year
- CHRW N/A
- NBIX $16.25
- Revenue Next Year
- CHRW $4.58
- NBIX $15.23
- P/E Ratio
- CHRW $23.26
- NBIX $44.36
- Revenue Growth
- CHRW N/A
- NBIX 21.73
- 52 Week Low
- CHRW $84.68
- NBIX $84.23
- 52 Week High
- CHRW $114.82
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- CHRW 51.26
- NBIX 58.15
- Support Level
- CHRW $96.34
- NBIX $127.03
- Resistance Level
- CHRW $102.58
- NBIX $135.94
- Average True Range (ATR)
- CHRW 2.06
- NBIX 2.93
- MACD
- CHRW 0.16
- NBIX 0.25
- Stochastic Oscillator
- CHRW 45.99
- NBIX 55.39
About CHRW C.H. Robinson Worldwide Inc.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 61% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (27%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of the European truck-brokerage division, transportation management services, and a legacy produce-sourcing operation.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.